Lisa Anson is the founder of Redx Pharma. Redx Pharma has raised $18M in total funding. Latest round: Series A. Backed by Redmile, Sofinnova, Polar Capital.
Lisa Anson is the Chief Executive Officer at Redx Pharma, appointed in 2018. She has transformed Redx into a clinical-stage biotech company with two programs in clinical development and a growing pipeline of preclinical assets. Her tenure has also seen the company secure major partnership deals and long-term financing.
Full founder directory · Investor directory · Company funding database · Fundraising library